It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine ...
Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25. Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft sales ...
Scientists say that officials from the National Institutes of Health urged them to remove references to mRNA vaccine ...
National Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their ...